Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

Similar documents
Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage

Global EHS Resource Center

Correct Site Rotation

Terms and Conditions. VISA Global Customer Assistance Services

World Connections Committee (WCC) Report

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Summary of Results for Laypersons

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

Main developments in past 24 hours

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

- Network for Excellence in Health Innovation

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB

Enriched RWE study in the Nordics a case study

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Chemical compatibility of the Pall QPoint TM Docking Station - Tap Assembly with common surface disinfectants

A Summary of Childhood Cancer Statistics in Australia,

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers NZ & Australia

ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET

Field of Post-M.D. Training

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Injection Technique (I.T.), Glycemic Variability, and Lipohypertrophy. Why I.T. All Matters

Sponsor. Generic Drug Name. Trial Indication(s) Protocol Number. Protocol Title. Clinical Trial Phase. Study Start/End Dates. Novartis.

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Allied Health: Sustainable Integrated Health Care for all Australians

CONNECTED HEALTH TRENDS

CND UNGASS FOLLOW UP

Appendix F: Test-Curriculum Matching Analysis

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Reza Fadayevatan Vida Alizad Ali Asgari

Louisville '19 Attachment #69

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Summary of Results for Laypersons

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

BioPlex 2200 Infectious Disease Panels

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Emily J. Hadgkiss, 1 George A. Jelinek, 1,2 Tracey J. Weiland, 1,3 Naresh G. Pereira, 4 Claudia H. Marck, 1 and Dania M.

NobelProcera Implant Bar Overdenture EXPERIENCE THE NEW WORLD OF CAD/CAM DENTISTRY

Tobacco: World Markets and Trade

THE CARE WE PROMISE FACTS AND FIGURES 2017

2010 Preventive Care Guidelines

Lessons learned from working with international injection technique guidelines

HPV Vaccines: Background and Current Status

ETB Data. there was. compared

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

3.1 PHASE 2 OF THE GLOBAL PROJECT

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network

Third Party Controls for Your Dade Behring Systems

ORBE Summary of Benefits

The Latest Consumer & Innovation Trends in Weight Management

Immunohematology. IH-QC Modular System. Select. Combine. Control.

Global Measles and Rubella Update November 2018

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

Global Measles and Rubella Update October 2018

Heart Health Exploring the OTC options

IMPLANTABLE MAGNETIC TRANSCUTANEOUS BONE CONDUCTION HEARING SYSTEM REIMBURSEMENT CODING GUIDE

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

EASY-Care program in Iran. Dr Reza Fadayevatan, MD, MPH, PhD Head of Ageing Department, The University of Social welfare and Rehabilitation Sciences

NobelDesign 1.3 Installation guide

Global Measles and Rubella Update. April 2018

WCPT COUNTRY PROFILE December 2017 SWEDEN

World Health Organization Organisation mondiale de la Santé

TGX and TGX Stain-Free FastCast Acrylamide Kits

Cardiac Assessment Controls

Cardiac Assessment Controls A critical element of reliable cardiac testing

Drug resistance TB in People Living with HIV: research questions and priorities.

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

FOOD TESTING RAPID'L.Mono Chromogenic Media. Detect Listeria Species in 24 Hours

For personal use only

Access to treatment and disease burden

EUROPEAN AEROSOL PRODUCTION

2017 GLOBAL PAIN INDEX (GPI) Better for Everyone

What is the extent of gender bias in bioinformatics?

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Health Care Providers:

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

PyroMark Q24 CpG MGMT Handbook

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine

Mystery Case - Answers Due September 17, Neurology Resident & Fellow Mystery Case. A 2-month old girl with difficulty swallowing

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

Summary of Results for Laypersons

The Global Summit of Women 2009 Santiago, Chile May 14-16

EMBARGOED UNTIL 22 JUNE PM CEST (GMT+2)

Multi-Country Opinion Research Survey TOPLINE RESULTS GLOBAL AVERAGE

WCPT COUNTRY PROFILE December 2017 HUNGARY

Transcription:

Injection Techniques Questionnaire (ITQ) WorldWide Results 2014-2015 Needle Gauge

BACKGROUND

All needles are at least twice as long as the skin is thick

More than twice as long

31G =.26mm Surface = 1 A = π x r 2

More than 70% greater area 29G =.34mm 31G =.26mm Surface X 1,71 Surface = 1 A = π x r 2

Centre for Sensory-Motor Interaction, Denmark: Egekvist H, Bjerring P, Arendt-Nielson L. Pain and mechanical injury to human skin following needle insertions. European Journal of Pain. 3:41-49, 1999

Results: penetration force

GAUGE

GAUGE

SPEED

SPEED

SPEED

SPEED

ANGLE

Pain

30G: 0,3112mm 31G:0,2604mm 32G:0,2350mm Surface X 1,76 Surface X 1,23 Surface = 1

STUDY OBJECTIVES Compare four different pen needle types THIN Wall 31Gx8mm vs normal Wall 31Gx8mm THIN Wall 31Gx5mm vs normal Wall 31Gx6mm Evaluate comfort and pain perception by using TW vs normal Wall pen needles

Rate pain perception on: the penetration of pen needle into skin With Normal Wall With Thin Wall no answer 1% no answer 1% not at all painful 19% not at all painful 70% hardly painful 57% painful 19% hardly painful 27% very painful 3% painful 2% extremely painful 2%

24

Bench testing The penetration force in a skin substitute was on average 23 % lower with the 5-bevel pen needles vs similar 3-bevel pen needles,

Make IT Easy Extra Thin-Wall Pen Needle Clinical Study Results Michael Gibney

NEXT Clinical Study - Results

What can we say based on these studies? The pain of an injection is reduced by: A smaller gauge needle An extra-thin wall A 5-bevel tip More rapid insertion

DESCRIPTIVE STATISTICS

What needle gauge did nurses observe? NEEDLE GAUGE % as per Nurse 29 3.0 30 13.5 31 47.6 32 35.8 31

How is Gauge associated with Needle Length? (both Nurse-Observed; results as %) Gauge NEEDLE LENGTH 29 30 31 32 4 mm 0 1.0 10.6 88.4 5 mm.5 3.2 80.6 15.6 6 mm 3.0 7.1 69.8 20.1 8mm 1.2 41.5 51.6 5.7

Gauge Percentages by Country (1) Country 29 30 31 32 USA 2.7 23.0 33.7 40.6 Canada.4 3.0 19.4 77.2 Russia.0 74.3 25.7.0 South Africa.0 12.4 71.4 16.2 Netherlands.0 3.4 65.5 31.0 Belgium.0.0 59.3 40.7 France 4.0 2.4 84.8 8.8 Spain 6.3.8 90.6 2.3 Italy 1.2.4 42.0 56.3 Switzerland.0 24.0 60.0 16.0 Austria.0 63.5 36.5.0

Gauge Percentages by Country (2) Country 29 30 31 32 UK 2.0 5.9 40.5 51.7 Denmark.0.0.0 100.0 Sweden.0.0 100.0.0 Poland.0 25.0 69.6 5.4 Germany.7 2.9 65.7 30.7 Perú.0.0 85.7 14.3 Mexico.0.0 100.0.0 Argentina.0 39.0 27.1 33.9 Brazil 44.3 20.0 29.7 5.9 Chile.0 95.2 4.8.0 Colombia.0 75.0 21.4 3.6

Gauge Percentages by Country (3) Country 29 30 31 32 Venezuela 52.4 23.8 19.0 4.8 Malaysia.0.0 91.7 8.3 Australia 2.3 9.3 30.2 58.1 Indonesia.0 15.4 46.2 38.5 Philippines 15.2 15.2 36.4 33.3 Singapore.0 34.8 56.5 8.7 S. Korea.6 1.1 40.0 58.3 China.6 4.3 61.2 33.9 Turkey.0 29.5 29.9 40.7 India.0 3.9 61.3 34.9 Ireland.0.0 42.9 57.1

Gauge Percentages by Country (4) Country 29 30 31 32 Finland.0 3.9 69.7 26.3 Czech Republic.0 45.1 53.5 1.4 Nicaragua.0.0 100.0.0 Taïwan.0.0 15.2 84.8 Saudi Arabia 10.4 18.8 28.8 42.1 United Arab Emirates 9.5 19.0 59.5 11.9 TOTAL 3.0 13.5 47.6 35.8

COMPARATIVE STATISTICS: DEMOGRAPHICS

Is Needle Gauge associated with Diabetes Type? Needle Gauge 29 30 31 32 T1DM 52 209 782 703 DM type % 3.0% 12.0% 44.8% 40.3% T2DM 115 513 1860 1286 % 3.0% 13.6% 49.3% 34.1% p = 0.076

Is needle gauge associated with age category of respondent? Needle Gauge 29 30 31 32 Adult 130 673 2335 1580 % 2.8% 14.3% 49.5% 33.5% Adolescent 4 30 139 151 Respondent % 1.2% 9.3% 42.9% 46.6% Child 10 9 55 80 % 6.5% 5.8% 35.7% 51.9% 3 rd Party 22 13 29 105 % 13.0% 7.7% 17.2% 62.1% p < 0.000

COMPARATIVE STATISTICS: ASSOCIATIONS

Is Needle Gauge associated with patient-reported LH? Gauge Lipohypertrophy Yes Lipos (patient reported) more frequent with largest diameter gauge, p = 0.002 No 29 63 106 37.3% 62.7% 30 229 527 30.3% 69.7% 31 894 1766 33.6% 66.4% 32 580 1425 28.9% 71.1%

Is Needle Gauge associated with Nurse-Observed LH? Gauge Lipohypertrophy Yes Lipos (Nurse-Observed) more frequent with largest diameter gauge, p < 0.000 No 29 60 103 36.8% 63.2% 30 220 486 31.2% 68.8% 31 824 1618 33.7% 66.3% 32 525 1361 27.8% 72.2%

Is Gauge associated to Pen Needle Reuse (patient reported)? Needle Gauge 29 30 31 32 Yes 24 308 1212 870 Reuse % 48.0% 52.8% 54.8% 45.1% No 26 275 998 1060 % 52.0% 47.2% 45.2% 54.9% Less PN reuse with 32 gauge, p < 0.000

Is Gauge associated to Pen Needle Reuse (nurse reported)? Needle Gauge 29 30 31 32 Yes 60 406 1522 889 Reuse % 35.7% 54.0% 57.4% 44.6% No 108 346 1131 1103 % 64.3% 46.0% 42.6% 55.4% Less PN reuse with 32 gauge, p < 0.000

Is Gauge associated to Syringe Reuse? Needle Gauge 29 30 31 32 Yes 38 144 442 110 Reuse % 28.1% 45.6% 48.3% 24.4% No 97 172 473 340 % 71.9% 54.4% 51.7% 75.6% Less syringe reuse with 32 gauge, p < 0.000

Is Needle Gauge associated with pain? Needle Gauge 29 30 31 32 Yes 75 346 1275 926 Pain % 48.4% 49.3% 52.5% 50.4% No 80 356 1154 912 % 51.6% 50.7% 47.5% 49.6% At 29G are we at pain-detection threshold?, p = 0.304

30G: 0,3112mm 31G:0,2604mm 32G:0,2350mm Surface X 1,76 Surface X 1,23 Surface = 1

Is Needle Gauge associated with bleeding? Needle Gauge 29 30 31 32 Yes 90 432 1545 1071 Pain % 52.6% 57.7% 58.4% 53.9% No 81 317 1099 915 % 47.4% 42.3% 41.6% 46.1% p = 0.013

Is Needle Gauge associated with Leaking from Site? Needle Gauge 29 30 31 32 Yes 59 264 968 760 Leaking from Site % 35.1% 35.2% 36.6% 38.4% No 109 487 1679 1221 % 64.9% 64.8% 63.4% 61.6% p = 0.370

Is Needle Gauge associated with Hypoglycemia? Needle Gauge 29 30 31 32 Yes 97 419 1522 1113 Hypos % 56.7% 55.9% 57.2% 55.7% No 74 330 1138 887 % 43.3% 44.1% 42.8% 44.4% p = 0.743

Is Needle Gauge associated with Correct Rotation? Needle Gauge 29 30 31 32 Yes 85 496 1818 1459 Correct Rotation % 52.1% 68.7% 70.0% 73.9% No 78 226 778 514 % 47.9% 31.3% 30.0% 26.1% p < 0.000

Conclusions (1) Needle gauge over the last decade has shifted significantly towards lower diameters (31 and 32G) This shift has tracked the move to shorter needle lengths, although not as dramatically. There is still a great deal of country variation in the distribution of different needle gauges. Adolescents and children use the thinnest gauge (32G) more frequently than adults.

Conclusions (2) For unknown reasons LH seems to be less frequent with 32G than the other gauges. Correspondingly, needle reuse seems to be lower with this gauge, while correct rotation seems to increase in frequency as the gauge thins. 32G needles are associated with less bleeding, but there are no apparent differences in injection pain, hypoglycemia or leaking from the site as a function of needle gauge. It may be that at or near 29G we reach the threshold for pain detection in the majority of patients.